Vita Life Sciences Limited (VLS.AX) Comparison with companies in other sectors?

Vita Life Sciences Limited has a share price of 54.32M. You can analyze Vita Life Sciences Limited (VLS.AX) competitors across different market sectors through stock heatmaps.

What are VLS.AX's NET and operating margins?

Vita Life Sciences Limited (VLS.AX) operating margin is around 0.15, and net profit margin is approximately 0.11 as of the latest reports.

In what way does VLS.AX's earnings per share (EPS) trend reflect its financial momentum?

Vita Life Sciences Limited (VLS.AX) EPS is 0.16 (If EPS value is positive, then “signals consistent profit growth” if Negative then “signals consistent loss”). This metric is also critical in assessing valuation metrics like the P/E ratio for Vita Life Sciences Limited is 13.81, and the company’s ability to reinvest or distribute profits.

What does a high ROE mean for Vita Life Sciences Limited?

A high ROE suggests efficient use of shareholder equity to generate profit. It often signals strong management and profitability.

How do I know if AAPL is overvalued or undervalued?

Check valuation ratios for Vita Life Sciences Limited like P/E which is 13.89, P/B which is 2.33, and PEG which is -2.36. Compare them with sector averages to evaluate if the stock is priced fairly.

Vita Life Sciences Limited

VLS.AX•ASX

Healthcare

Drug Manufacturers - Specialty & Generic

A$2.21

A$0.00(0.00%)

Vita Life Sciences Limited (VLS.AX) Fundamental Analysis: Financial Health, Valuation, and Key Ratios

Dive into Apple Inc.’s fundamentals including valuation ratios, profitability, efficiency metrics, and financial health. Use this data to assess long-term investment quality and compare it with sector benchmarks.

EPS (TTM)

$0.16

P/E Ratio

13.81

ROE

0.17%

Net Margin

0.11%

Key Financial Metrices

Valuation Metrics

4 metrics

Market CapTotal market value of outstanding shares

$120.05M

Shares OutstandingTotal number of shares issued

$54.32M

Book Value/ShareNet worth per share

$0.95

Revenue/ShareAnnual revenue per share

$1.44

Profitability Metrics

6 metrics

EPS (TTM)Earnings per share trailing twelve months

$0.16

Net MarginNet income as percentage of revenue

11.05%

Operating MarginOperating income as percentage of revenue

14.95%

ROEReturn on shareholders' equity

17.37%

ROAReturn on total assets

12.22%

ROCEReturn on capital employed

22.59%

Cash Flow Metrics

3 metrics

Free Cash Flow/ShareCash generated per share after capex

$0.11

Cash/ShareCash and equivalents per share

$0.52

FCF YieldFree cash flow as percentage of market cap

4.96%

Dividend Metrics

2 metrics

Dividend/ShareAnnual dividend payment per share

$0.10

Dividend YieldAnnual dividend as percentage of stock price

4.52%

Financial Ratios Analysis data is not available for VLS.AXFinancial Ratios Analysis details for VLS.AX are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Sector Benchmarking data is not available for VLS.AXSector Benchmarking details for VLS.AX are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Understanding Fundamental Analysis for Vita Life Sciences Limited Investment Decisions

What is Fundamental Analysis?

Fundamental analysis is a method used to assess the intrinsic value of Vita Life Sciences Limited. Using financial reports, management structure, competitive position, and market environment, investors can determine whether the stock is undervalued or overvalued. This analysis helps investors like you make more informed investment decisions, taking into account Vita Life Sciences Limited's unique business strengths and challenges.

Key Financial Metrics for Vita Life Sciences Limited

For Vita Life Sciences Limited, essential financial indicators include EPS 0.16, PE 13.81, and ROE 0.17. These key ratios reveal insights into Vita Life Sciences Limited's profitability, valuation, and operational health. Understanding these metrics enables you to compare Vita Life Sciences Limited with its industry peers and decide whether it presents a viable investment opportunity.

Profitability and Operational Efficiency of Vita Life Sciences Limited

Metrics like Net Margin 11.05% and ROA 12.22% shed light on how well Vita Life Sciences Limited is generating profits. A high profitability ratio often indicates strong management and a solid business model, which are essential for long-term growth. These metrics are crucial in assessing whether Vita Life Sciences Limited can sustain its operations and continue growing in the future.

Valuation and Market Position of Vita Life Sciences Limited

Using ratios such as P/B Ratio 2.33 and PEG Ratio -2.36, investors can assess whether Vita Life Sciences Limited is appropriately valued based on its financials and growth potential. These figures, combined with Vita Life Sciences Limited's market capitalization, give insight into its competitive positioning and investor expectations, helping you make informed decisions on pricing and value.

Financial Health and Risk Assessment for Vita Life Sciences Limited

Financial health indicators, such as Debt/Equity Ratio 0.010 and Cash Flow $0.11, provide a snapshot of Vita Life Sciences Limited's ability to meet financial obligations and handle economic setbacks. A company with a strong balance sheet and solid cash flow, like Vita Life Sciences Limited, is more likely to weather financial storms, making it a safer investment.

Long-Term Investment Strategy for Vita Life Sciences Limited

Investing in Vita Life Sciences Limited based on fundamental analysis emphasizes long-term business growth rather than short-term market trends. Investors looking at Vita Life Sciences Limited focus on its solid financial performance, industry standing, and competitive advantages, all of which suggest sustainable growth and the potential for steady returns over time.

Fundamental Analysis FAQ

;